FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk to Public Health. The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.